Today, smart wearables and health tracking apps are part of everyday life for millions of people in the UK. From heart rate and blood oxygen levels to continuous glucose readings and home ECGs, a growing share of the population is generating real time health data from their wrist, phone or patch.
This is more than a consumer trend: it is fundamentally changing how patients understand their own health and their awareness of what medical technology can offer. Patients no longer arrive at appointments in the dark about their health.
Rather, they present months of data to clinicians, who can then use this information to support their own decision-making.
Founder and CEO, Health Tech Alliance.
It is important, however, to distinguish between consumer wellness wearables and regulated medical devices (such as CE- or UKCA-marked technologies) that inform diagnosis and treatment in clinical pathways supported by NICE guidance.
We see this shift towards on-the-go health tech across the industry including developers of wearable cardiac monitors, continuous glucose systems, therapeutic wearables and portable diagnostic tools.
The public taking prevention into their own hands
Wearables have not only normalized constant and convenient access to health information, but have also empowered individuals to take personal responsibility for their own health. Checking a resting heart rate or sleep pattern has become routine, often prompting earlier referral to NHS services when anomalies appear.
Fitness trackers were the catalyst, but the public is now increasingly familiar with clinically focused technologies. Their presence in pharmacies, online, and in the media has raised awareness that precise, preventative tools exist, even when not supplied through the NHS.
Patient autonomy and appetite for diagnostics
This growth in patient autonomy has direct implications for health tech adoption. A decade ago, wearing a cardiac monitor for longer than 24 hours might have deterred patients; today, many people have adapted to this change, wearing devices day and night.
Key implications of this shift for health tech adoption include:
1. Willingness to use clinical devices: Familiarity with wearables makes patients open to long-term clinical monitoring if it yields a definitive result.
2. Stronger demand for accuracy: Patients understand that a 24-hour snapshot can miss intermittent issues and are more inclined to support technologies that monitor over days or weeks, even if this requires more commitment in the short term.
3. Reduced tolerance for repeat appointments caused by inconclusive tests: Once patients realize high-quality data prevents repeated hospital visits, they naturally prefer comprehensive, first-time investigation.
Ambulatory ECG monitoring illustrates this well. Traditional 24-hour Holter monitors frequently miss intermittent arrhythmias, leading to delayed diagnoses and increased stroke risk. Modern devices monitoring for 14 days provide higher diagnostic yields and a far better patient experience.
When tariffs lag behind patient expectations
Unfortunately, we often see that NHS reimbursement structures rarely keep pace. Long-term monitoring technologies are often grouped under the same tariff codes as short-duration, less accurate options.
In ambulatory ECG, for example, extended continuous monitoring is frequently reimbursed at the same rate as a basic Holter monitor. This structurally disincentivizes providers from adopting more effective diagnostics, compelling Trusts to rely on cheaper, short-term tests that fit existing codes but result in avoidable repeat appointments.
To harness patient autonomy in support of health tech adoption, reimbursement must recognize wider system benefits – such as avoided admissions and reduced outpatient appointments – rather than focusing solely on unit cost.
Supporting bringing care closer to home
These issues are particularly relevant in the context of the Neighbourhood Health Framework and 10 Year Health Plan. Moving toward integrated neighborhood teams and prevention-focused, community-based care depends on timely insight into patient risk.
Neighborhood teams are expected to manage long term conditions closer to home, prevent avoidable non-elective admissions and reduce pressure on acute services. Virtual wards are already doing this at scale: in January 2026, more than 11,000 patients in England were being cared for on virtual wards, with around 90% of the 12,700 available ‘beds’ occupied. Patient-generated data from wearables can support this by flagging risk earlier, enabling timely intervention and safe remote follow-up.
Longer term monitoring, postal diagnostic pathways and remote review are consistent with the Framework’s aims. They can contribute to mandated success measures, including reductions in non-elective admissions and bed days, improvements in cardiovascular and diabetes outcomes, better access and fewer avoidable outpatient appointments.
However, local providers will only realize this potential if adoption and market access mechanisms are aligned. If tariffs and coding frameworks undervalue longer-term monitoring, local systems will struggle to invest in the tools that best support these objectives.
Harnessing the “wearable generation” for system change
The rise of health tracking has created a population comfortable with health data, more focused on prevention and more aware of the possibilities of health technology. Whilst this can lead to more ‘worried well’ presentations – where non‑specific alerts from consumer wearables drive anxiety and extra GP appointments – it is largely an asset for the NHS.
The answer is not to discourage engagement, but to channel it. Clear guidance on how consumer data should be interpreted, and regulated devices with proven accuracy sitting within structured pathways rather than operating in isolation, can reduce unnecessary demand while accelerating appropriate diagnosis and treatment.
If procurement and commissioning are adjusted to reflect this reality, informed patients can accelerate responsible health tech adoption. They are already willing to track their health, use monitoring devices for longer periods and engage with digital tools if this results in clearer answers and less time on waiting lists.
The task now is to ensure that adoption pathways, tariffs and neighborhood care models are designed to support this engagement and to translate prevention on the wrist into better outcomes for patients and the health system.
We feature the best telemedicine software.
This article was produced as part of TechRadar Pro Perspectives, our channel to feature the best and brightest minds in the technology industry today.
The views expressed here are those of the author and are not necessarily those of TechRadarPro or Future plc. If you are interested in contributing find out more here: https://www.techradar.com/pro/perspectives-how-to-submit
https://cdn.mos.cms.futurecdn.net/66VqvPPDZuo2kdKYFpXWkK-2560-80.jpg
Source link
